Fidia S.p.A. (BIT:FDA)

Italy flag Italy · Delayed Price · Currency is EUR
0.3440
+0.0029 (0.85%)
Jul 9, 2025, 5:35 PM CET
-99.50%
Market Cap 2.57M
Revenue (ttm) 17.53M
Net Income (ttm) -9.30M
Shares Out 7.47M
EPS (ttm) -32.85
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 894,177
Average Volume 571,661
Open 0.3411
Previous Close 0.3411
Day's Range 0.3380 - 0.3740
52-Week Range 0.2000 - 71.4000
Beta 0.02
RSI 37.40
Earnings Date Sep 11, 2025

About Fidia

Fidia S.p.A., together with its subsidiaries, designs, manufactures, and sells high speed milling systems, numerical controls, milling heads, and software systems. Its accessories comprise HMS, a device for measuring and compensating geometric error on continuous or indexed bi-rotary heads and roto-tilting tables; TMSC, a device to measure length and diameter of the tool, as well as to check the shape; K5 tracer, a solution to perform continuous scanning of 3D surfaces; pushbutton panels; XPower digital drives for axis and spindle movement; and... [Read more]

Sector Industrials
Founded 1974
Employees 159
Stock Exchange Borsa Italiana
Ticker Symbol FDA
Full Company Profile

Financial Performance

In 2024, Fidia's revenue was 17.53 million, a decrease of -38.98% compared to the previous year's 28.74 million. Losses were -9.30 million, 611.4% more than in 2023.

Financial Statements

News

Zepbound Powers Eli Lilly's Upbeat Q2 Outlook

Eli Lilly and Co. (NYSE: LLY) is set to release its second-quarter earnings on August 7. According to Benzinga Pro data, analysts are anticipating adjusted earnings of $5.56 per share and sales of $1...

10 hours ago - Benzinga

Johnson & Johnson's Outlook Clouded By $2 Billion Headwind

Johnson & Johnson (NYSE: JNJ) is set to release its second-quarter earnings on Wednesday, July 16. According to Benzinga Pro data, analysts estimate adjusted earnings of $2.68 per share and sales of ...

10 hours ago - Benzinga

Gilead's Lenacapavir Plan Faces Global Hurdles As It Commits To No-Profit Access for 2 Million

Gilead Sciences, Inc . (NASDAQ: GILD) on Wednesday announced a strategic partnership agreement with the Global Fund to Fight AIDS, Tuberculosis and Malaria to supply lenacapavir — Gilead’s twice-year...

12 hours ago - Benzinga

Inovio wins new Overweight at Piper Sandler on potential FDA nod for lead drug

Inovio Pharmaceuticals (NASDAQ:INO) stock rises as Piper Sandler issues new Overweight rating, citing FDA approval for its lead drug INO-3107 next year. Read more here.

13 hours ago - Seeking Alpha

Evoke Pharma (EVOK) Shares Skyrocket On New Patent: What's Going On?

Shares of Evoke Pharma Inc (NASDAQ: EVOK) are trading sharply higher Wednesday morning after the specialty pharmaceutical company announced it has received a Notice of Allowance from the U.S. Patent ...

13 hours ago - Benzinga

FDA Approves New Dosing Schedule For Eli Lilly's Kisunla In Alzheimer's Treatment

The U.S. Food and Drug Administration (FDA) has approved a label update with a new recommended titration dosing schedule for Eli Lilly and Co.’s (NYSE: LLY) Kisunla (donanemab-azbt) once-monthly amyl...

15 hours ago - Benzinga

This Palantir Partnership Uses AI And Satellites To Predict Weather Like Never Before - Here's What It Means

Palantir Technologies Inc. (NASDAQ: PLTR) shares are trading relatively flat in the premarket session on Tuesday. The company has teamed up with Tomorrow.io , a weather analytics and resilience firm,...

16 hours ago - Benzinga

Emcure’s Sanand oncology facility clears US FDA inspection with zero observations

Emcure Pharmaceuticals Limited announced that its oncology manufacturing facility in Sanand, Ahmedabad has successfully cleared a Pre-Approval Inspection (PAI) conducted by the US Food and Drug Admini...

16 hours ago - Business Upturn

Illegal kratom drink factory raided in Samut Prakan

Police and Food and Drug Administration (FDA) officials raided a major producer of kratom-laced drinks in Samut Prakan province on Wednesday and seized over 200,000 baht worth of illegal products.

17 hours ago - Bangkok Post

Alvotech Expands its Capacity in Assembly and Packaging with the Acquisition of Ivers-Lee in Switzerland

REYKJAVIK, Iceland and BURGDORF, Switzerland, July 09, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicin...

20 hours ago - Benzinga

KalVista: FDA Approval Of EKTERLY As Oral On-Demand HAE Drug Is Just Beginning

FDA approval of EKTERLY makes KalVista Pharmaceuticals, Inc. the first to offer an oral on-demand HAE therapy. Click here to find out why KALV is a Strong Buy.

1 day ago - Seeking Alpha

Cogent's Chronic Immune Disorder Drug Has Strong Potential To Become A Blockbuster: Analyst

Cogent's bezuclastinib showed strong efficacy in a non-advanced SM trial, with a planned FDA submission expected by the end of 2025. Latest Ratings for COGT ... Full story available on Benzinga.com

1 day ago - Benzinga

MedPlus subsidiary faces 5-day drug license suspension for Thane store

MedPlus Health Services Limited informed stock exchanges that its subsidiary, Optival Health Solutions Private Limited, has received a suspension order from the Food and Drug Administration (FDA), Mum...

1 day ago - Business Upturn

Why Is Penny Stock ProKidney Trading Higher On Tuesday?

ProKidney Corp. (NASDAQ: PROK) stock is trading higher on Tuesday, with a session volume of 39.8 million compared to the average volume of 1.12 million as per data from Benzinga Pro . What happened: ...

1 day ago - Benzinga

Medical groups urge Kennedy, FDA to reexamine broad approval of abortion drugs

Pro-life medical groups are urging Health and Human Services Secretary Robert Kennedy Jr. to reexamine the FDA’s broad approval of abortion drugs after the Biden administration expand their use.

1 day ago - Fox News

Palantir Co-Founder Joe Lonsdale Wants A FDA Overhaul With Special Forces-Style AI Team Because China Is Racing To Outpace US In Biotech

On Monday, Palantir Technologies Inc. (NASDAQ: PLTR) co-founder Joe Lonsdale urged a tech-driven transformation of the Food and Drug Administration , warning that bureaucratic inertia is putting the ...

1 day ago - Benzinga

FDA Issues Early Alert For Johnson & Johnson's Abiomed Heart Pump Controllers

Johnson & Johnson’s (NYSE: JNJ) Abiomed has issued an Early Alert regarding its Automated Impella Controllers (AIC) for Impella heart pumps, a device crucial for patients with severe heart conditions...

2 days ago - Benzinga

​FDA directs eateries to stop operations due to unhygienic conditions, destroys food

Panaji: The directorate of food and drugs administration (FDA) directed a catering business at Parra, supplying tiffins to around 300 customers in Ca.

2 days ago - The Times of India

Even low doses of CBD may cause harm to the liver in some people, FDA study finds

From capsules, gummies and other edibles, to oils and lotions, CBD products have become increasingly popular in the United States.

2 days ago - NBC News

Hims & Hers Navigates Novo Nordisk Breakup And Compounding Lawsuits

Hims & Hers Health, Inc. (NYSE: HIMS) is currently experiencing a decline in its stock price, trading lower on Monday. The company’s stock has plummeted approximately 18% over the past month, reflect...

2 days ago - Benzinga

KalVista Pharmaceuticals, Cogent Biosciences, WNS And Other Big Stocks Moving Higher On Monday

U.S. stocks were lower, with the Dow Jones index falling over 100 points on Monday. Shares of KalVista Pharmaceuticals, Inc . (NASDAQ: KALV) rose sharply during Monday's session after the company ann...

2 days ago - Benzinga

KalVista Ends Its Unexpectedly Messy Path To Approval In HAE Treatment

The FDA signed off on KalVista Pharmaceuticals' emergency treatment for swelling attacks associated with a rare, genetic disease.

2 days ago - Investor's Business Daily

FDA Approves KalVista's Ekterly As First Oral On-Demand Treatment For Rare Swelling Disease

KalVista's Ekterly, backed by strong trial data, ... Full story available on Benzinga.com

2 days ago - Benzinga

CorFlow Therapeutics Announces FDA Approval of the MOCA-II IDE Pivotal Trial to Validate a Novel Heart Attack Care Technology

BAAR, Switzerland — CorFlow Therapeutics AG (CorFlow), a pioneering company in the field of cardiac care targeting microvascular disease, today announced that the U.S. Food & Drug Administration (FDA)...

2 days ago - Financial Post

FDA shuts food units over hygiene, licence violations

Panaji: The directorate of food and drugs administration (FDA) in an inspection drive at Tiswadi and Bardez, directed six food outlets to cease operat.

3 days ago - The Times of India

Patients with ultra-rare diseases worry new FDA rules will leave them without treatment

Testing is difficult for drugs for rare diseases, and new rules may make it harder for sufferers to obtain life-saving drugs US drug regulators have increasingly signaled a focus on faster approvals a...

3 days ago - The Guardian

How sensationalized headlines about 'brain plastic' are undermining trust in safe, sustainable materials

Microplastics research faces standardization challenges as viral headlines about "plastic in your brain" overshadow scientific nuance, while FDA finds no evidence of health risks.

4 days ago - Fox News

Maharashtra FDA lens on gutka ads, its home delivery, says minister Narhari Zirwal in legislative assembly

Mumbai: State FDA minister Narhari Zirwal on Friday told the assembly that it will crack down on pan masala ads, online delivery apps that sell pan ma.

5 days ago - The Times of India

Firm blacklisted for spurious drug supply in Vasai

Mumbai: The Vasai Virar City Municipal Corporation (VVCMC) has blacklisted m/s Pranic Enterprises, Nalasopara west, after it was proved by the FDA tha.

5 days ago - The Times of India

Former FDA chief: Ultraprocessed foods are addictive like drugs

Food companies design products to hit what they call the "bliss point" that triggers reward circuits.

6 days ago - Yahoo

New drug registered with FDA

The Government Pharmaceutical Organisation (GPO) has registered the affordable hepatitisC drug ravidasvir with the Food and Drug Administration to improve access for 800,000 patients and reduce treatm...

6 days ago - Bangkok Post

New drug to be registered with FDA

The Government Pharmaceutical Organisation (GPO) has prepared to register the affordable hepatitisC drug ravidasvir with the Food and Drug Administration to improve access for 800,000 patients and red...

6 days ago - Bangkok Post

FDA upgrades blueberry recall to highest risk level

The Food and Drug Administration (FDA) upgraded a blueberry recall this week to the highest risk level amid concerns of contamination. The FDA raised the recall of 400 boxes that weigh 30 pounds to Cl...

6 days ago - The Hill

RFK Jr. Influence Evident As Vaccine Chief Overrules Scientists, Limits COVID-19 Vaccine Approval

Dr. Vinay Prasad , the U.S. Food and Drug Administration’s (FDA) top vaccine official, overruled agency scientists to limit approval of two COVID-19 vaccines, despite internal recommendations to clear...

6 days ago - Benzinga

Novartis' Cosentyx Fails Late-Stage Giant Cell Arteritis Trial

Novartis AG (NYSE: NVS) on Thursday released topline results from the Phase 3 GCAptAIN study evaluating Cosentyx (secukinumab) for newly diagnosed or relapsing giant cell arteritis (GCA) . Giant cell...

6 days ago - Benzinga

RFK Jr.‘s top FDA vaccine official restricts 2 COVID vaccine approvals against advice of agency scientists

The new memos from the FDA show how the agency’s vaccine chief, Dr. Vinay Prasad, personally intervened to place restrictions on COVID shots from vaccine makers Novavax and Moderna.

6 days ago - Fortune

How Zevra's Miplyffa Could Transform Investment Strategies

Zevra Therapeutics, Inc. (NASDAQ: ZVRA) is turning a quiet FDA approval into a broader comeback story. HC Wainwright initiated coverage on the rare disease drugmaker with a Buy rating and a $26 price...

7 days ago - Benzinga

Merck's Hypertension Drug On FDA Fast Track For Label Expansion

The U.S. Food and Drug Administration (FDA) has accepted and granted priority review for Merck & Co. Inc.’s (NYSE: MRK) new supplemental Biologics License Application (sBLA) seeking approval to updat...

7 days ago - Benzinga